NewEdge Wealth’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5M Buy
51,943
+2,166
+4% +$1,000K 0.27% 81
2026
Q1
$23.9M Buy
49,777
+45,428
+1,045% +$23.3M 0.28% 79
2025
Q4
$2.44M Buy
4,349
+371
+9% +$211K 0.03% 400
2025
Q3
$2.38M Sell
3,978
-904
-19% -$395K 0.03% 350
2025
Q2
$2.09M Buy
4,882
+3,511
+256% +$1.05M 0.03% 370
2025
Q1
$418K Buy
1,371
+163
+13% +$54.8K 0.01% 698
2024
Q4
$401K Buy
1,208
+452
+60% +$153K 0.01% 689
2024
Q3
$252K Buy
+756
New +$287K ﹤0.01% 772

Other funds holding MEDP

NewEdge Wealth's MEDP Position: Q2 2026 in Review

NewEdge Wealth increased its Medpace (MEDP) stake by 4.4% in Q2 2026, buying an estimated $1,000K and bringing the position to 51,943 shares worth $27.5M. The position accounts for 0.27% of the portfolio, ranked #81.

NewEdge Wealth first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • NewEdge Wealth held 51,943 shares of Medpace worth $27.5M as of Q2 2026.
  • NewEdge Wealth bought 2,166 Medpace shares in Q2 2026, an estimated $1,000K.
  • Medpace made up 0.27% of NewEdge Wealth's portfolio in Q2 2026, its #81 holding.
  • NewEdge Wealth first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.